Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats

OBJECTIVES: Mesenchymal stem cells derived from human amniotic fluid (hAFSCs) are a promising source for cellular therapy, especially for renal disorders, as a subpopulation is derived from the fetal urinary tract. The purpose of this study was to evaluate if hAFSCs with a renal progenitor phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteiro Carvalho Mori da Cunha, Marina Gabriela, Zia, Silvia, Oliveira Arcolino, Fanny, Carlon, Marianne Sylvia, Beckmann, Diego Vilibaldo, Pippi, Ney Luis, Luhers Graça, Dominguita, Levtchenko, Elena, Deprest, Jan, Toelen, Jaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546614/
https://www.ncbi.nlm.nih.gov/pubmed/26295710
http://dx.doi.org/10.1371/journal.pone.0136145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546614/
https://www.ncbi.nlm.nih.gov/pubmed/26295710
http://dx.doi.org/10.1371/journal.pone.0136145

Ejemplares similares